Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory ...

The COVID-19 mRNA vaccine generates enough of an antibody response to protect against severe disease for six months. But ...

Bispecific antibodies (BsAbs) are a major advancement in therapeutic oncology and hematology, capable of simultaneously engaging two distinct targets. This ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the ...

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

Researchers at the University of Gothenburg, Sweden, in collaboration with colleagues in China, have discovered an ...